Found: 89
Select item for more details and to access through your institution.
Correction to: Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5102, doi. 10.1002/alz.13883
- By:
- Publication type:
- Article
Quantification supports visual assessment of challenging amyloid‐PET images.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074620
- By:
- Publication type:
- Article
Evaluating the sensitivity of Centiloid quantification to pipeline design and image harmonization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074616
- By:
- Publication type:
- Article
Correlations between [<sup>18</sup>F]flutemetamol PET and region‐matched postmortem integrated density measures of cyano‐flutemetamol signal in Aβ plaques.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080306
- By:
- Publication type:
- Article
Comparing parametric methods for longitudinal measurement of β‐amyloid pathology with PET in elderly individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079545
- By:
- Publication type:
- Article
CSF Biomarkers and [<sup>18</sup>F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074779
- By:
- Publication type:
- Article
Biological and methodological factors underlying a continuous amyloid CSF/PET imbalance model and its association with longitudinal cognition.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074607
- By:
- Publication type:
- Article
Prediction of longitudinal cortical amyloid deposition based on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively unimpaired individuals: the role of APOE‐ε4.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076943
- By:
- Publication type:
- Article
Evaluating the sensitivity of Centiloid quantification to pipeline design and image harmonization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.082036
- By:
- Publication type:
- Article
Correlations between [18F]flutemetamol PET and region‐matched postmortem integrated density measures of cyano‐flutemetamol signal in Aβ plaques.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081997
- By:
- Publication type:
- Article
Comparing parametric methods for longitudinal measurement of β‐amyloid pathology with PET in elderly individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081913
- By:
- Publication type:
- Article
CSF Biomarkers and [18F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081661
- By:
- Publication type:
- Article
Biological and methodological factors underlying a continuous amyloid CSF/PET imbalance model and its association with longitudinal cognition.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081653
- By:
- Publication type:
- Article
Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 5232, doi. 10.1002/alz.13158
- By:
- Publication type:
- Article
IC‐P‐012: CONFOCAL ANALYSIS OF FLUORESCENT SIGNAL DERIVED FROM CN‐FLUTEMETAMOL LABELED DIFFUSE AND NEURITIC PLAQUES IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 14, p. P21, doi. 10.1016/j.jalz.2018.06.2076
- By:
- Publication type:
- Article
Inverse relationship between education and amyloid burden in individuals with subjective cognitive decline plus and mild cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.064097
- By:
- Publication type:
- Article
Evaluating the sensitivity of Centiloid quantification to pipeline design and image resolution.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067896
- By:
- Publication type:
- Article
Impact of reduced injected dose on semi‐quantification of in vivo amyloid‐β pathology using [<sup>18</sup>F]flutemetamol.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.066748
- By:
- Publication type:
- Article
Evaluating the sensitivity of Centiloid quantification to pipeline design and image resoloution.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.062330
- By:
- Publication type:
- Article
Quantitative amyloid‐PET measures in a memory clinic population.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.062326
- By:
- Publication type:
- Article
Evaluation of novel data‐driven metrics of amyloid β deposition for longitudinal PET studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.064612
- By:
- Publication type:
- Article
Structural, metabolic and cognitive characteristics of cognitively unimpaired subjects with mismatching β‐amyloid biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052507
- By:
- Publication type:
- Article
A novel regional centiloid atlas to investigate the relationship between the quantification of [<sup>18</sup>F]flutemetamol amyloid PET and CSF Aβ42/40 in patients with SCD or MCI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056019
- By:
- Publication type:
- Article
Evaluating robustness of the Centiloid scale against variations in amyloid PET image resolution.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055726
- By:
- Publication type:
- Article
Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 5, p. 788, doi. 10.1002/alz.12245
- By:
- Publication type:
- Article
Impact of APOE‐ε4 on cerebral amyloid deposition in participants with abnormal soluble amyloid levels: Amyloid imaging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045828
- By:
- Publication type:
- Article
Harmonization of amyloid PET scans minimizes the impact of reconstruction parameters on centiloid values: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045294
- By:
- Publication type:
- Article
Weight loss predicts Alzheimer's disease biomarker positivity in cognitively unimpaired middle‐aged adults: Epidemiology: Cardiovascular risk factors.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045137
- By:
- Publication type:
- Article
Multiple biological pathways associate with cerebral amyloid load in the early Alzheimer's continuum: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044733
- By:
- Publication type:
- Article
A multi‐study analysis of the spatial‐temporal progression of amyloid deposition and its utility for longitudinal studies: The value of amyloid PET beyond dichotomization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044707
- By:
- Publication type:
- Article
Classification of <sup>18</sup>F‐flutemetamol scans using machine learning with neuropathology as standard of truth: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044550
- By:
- Publication type:
- Article
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [<sup>18</sup>F]flutemetamol PET images: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043157
- By:
- Publication type:
- Article
Examining centiloid quantification against visual assessment using [18F]flutemetamol PET: The value of amyloid PET beyond dichotomization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042653
- By:
- Publication type:
- Article
Baseline features of the AMYPAD Diagnostic and Patient Management Study (DPMS) participants: Neuroimaging / differential diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042628
- By:
- Publication type:
- Article
Impact of the disclosure of amyloid‐PET results to patients with subjective cognitive decline: the AMYPAD Diagnostic and Patient Management Study (DPMS): Neuroimaging / Normal brain aging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040952
- By:
- Publication type:
- Article
P4‐307: THE ADDED VALUE OF QUANTITATIVE AMYLOID PET IN DETERMINING ALZHEIMER'S DISEASE (AD) DEMENTIA RISK: THE AMYPAD PROGNOSTIC AND NATURAL HISTORY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1408, doi. 10.1016/j.jalz.2019.06.3977
- By:
- Publication type:
- Article
F4‐03‐03: SELECTIVITY OF PET AMYLOID IMAGING LIGANDS IN THE ALZHEIMER'S DISEASE NEUROPATHOLOGY SPECTRUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1222, doi. 10.1016/j.jalz.2019.06.4724
- By:
- Publication type:
- Article
P3‐373: AMYPAD‐DPMS PRELIMINARY RESULTS: PARTICIPANTS' BASELINE FEATURES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1090, doi. 10.1016/j.jalz.2019.06.3406
- By:
- Publication type:
- Article
AMYPAD Diagnostic and Patient Management Study: Rationale and design.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 3, p. 388, doi. 10.1016/j.jalz.2018.09.003
- By:
- Publication type:
- Article
IC‐P‐012: CONFOCAL ANALYSIS OF FLUORESCENT SIGNAL DERIVED FROM CN‐FLUTEMETAMOL LABELED DIFFUSE AND NEURITIC PLAQUES IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P21, doi. 10.1016/j.jalz.2018.06.2076
- By:
- Publication type:
- Article
Infrequent false positive [<sup>18</sup>F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0387-6
- By:
- Publication type:
- Article
AMYLOID PET UTILITY IN CLINICAL PRACTICE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P398, doi. 10.1016/j.jalz.2017.06.379
- By:
- Publication type:
- Article
DETERMINATION OF NEURITIC VERSUS DIFFUSE PLAQUE CONTRIBUTION TO SIGNAL DERIVED FROM CN-FLUTEMETAMOL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1115, doi. 10.1016/j.jalz.2017.06.1614
- By:
- Publication type:
- Article
DETERMINATION OF NEURITIC VERSUS DIFFUSE PLAQUE CONTRIBUTION TO SIGNAL DERIVED FROM CN-FLUTEMETAMOL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P16, doi. 10.1016/j.jalz.2017.06.2283
- By:
- Publication type:
- Article
THE AMYPAD-DX CONTROLLED TRIAL ON THE DIAGNOSTIC VALUE OF AMYLOID PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1523, doi. 10.1016/j.jalz.2017.07.653
- By:
- Publication type:
- Article
[18F]FLUTEMETAMOL AMYLOID SCANNING IN A PHASE III AMNESTIC MILD COGNITIVE IMPAIRMENT STUDY: ADDITIONAL INFLUENCE OF OTHER BIOMARKERS IN ESTIMATING RISK OF CONVERSION TO PROBABLE ALZHEIMERS DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P221, doi. 10.1016/j.jalz.2017.07.100
- By:
- Publication type:
- Article
METHODOLOGICAL AND LOGISTIC STRATEGIES FOR A LARGE MULTI-CENTER β-AMYLOID PET EUROPEAN PROJECT: AMYLOID IMAGING TO PREVENT ALZHEIMER’S DISEASE (AMYPAD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P794, doi. 10.1016/j.jalz.2017.06.1074
- By:
- Publication type:
- Article
AMYPAD: A EUROPEAN PUBLIC-PRIVATE PARTNERSHIP TO INVESTIGATE THE VALUE OF β-AMYLOID BRAIN SCANS AS A DIAGNOSTIC AND THERAPEUTIC MARKER FOR ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P420, doi. 10.1016/j.jalz.2017.06.411
- By:
- Publication type:
- Article
MEASUREMENT OF PATHOLOGICAL AMYLOID IN ROUTINE CLINICAL ASSESSMENT: THE CLINICAL IMPACT OF VISUAL [18F]FLUTEMETAMOL PET AND CSF ANALYSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P411, doi. 10.1016/j.jalz.2017.06.397
- By:
- Publication type:
- Article